Nintedanib-Induced Renal Thrombotic Microangiopathy
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline in patients with IPF. Since vascular endothelial g...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-07-01
|
Series: | Case Reports in Nephrology and Dialysis |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/517692 |